Cyprus vs Marshall Islands: New or unknown treatment history cases: Pulmonary, bacteriologically
Cyprus
74
in 2022
Marshall Islands
86
in 2023
Cyprus rank
163rd
Marshall Islands rank
160th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Cyprus
- Marshall Islands
How they compare
Marshall Islands currently reports 86 against 74 in Cyprus, a difference of 12.
That makes Marshall Islands's figure about 1.2 times Cyprus's.
The two have swapped places 5 times across 10 shared years of data; in 2013 it was Marshall Islands ahead.
Cyprus ranks 163rd and Marshall Islands ranks 160th of 197 countries.
Across the 2 decades both report, Cyprus averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | Cyprus | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.14 | 62 | 24.86 | Marshall Islands |
| 2020s | 44.33 | 28.67 | 15.67 | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Cyprus or Marshall Islands?
- Marshall Islands, at 86 against 74 in Cyprus as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Cyprus and Marshall Islands?
- 12, with Marshall Islands ahead.
- How many years of comparable data are there for Cyprus and Marshall Islands?
- 10 years are reported by both, from 2013 to 2022.
- How do Cyprus and Marshall Islands rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Cyprus ranks 163rd and Marshall Islands ranks 160th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.